S227: SBNO2 IS A SPECIFIC DEPENDENCY OF STAT3-DRIVEN T-CELL MALIGNANCIES

• T. Brandstoetter,
• B. Maurer,
• J. Schmoellerl,
• S. Kollmann,
• J. Huuhtanen,
• R. Grausenburger,
• S. Mustjoki,
• J. Zuber,
• V. Sexl

Affiliations

T. Brandstoetter

1 Dept. of Biomedical Sciences at the Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

B. Maurer

1 Dept. of Biomedical Sciences at the Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

J. Schmoellerl

2 Research Institute of Molecular Pathology, Vienna, Austria

S. Kollmann

1 Dept. of Biomedical Sciences at the Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

J. Huuhtanen

3 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki

R. Grausenburger

1 Dept. of Biomedical Sciences at the Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

S. Mustjoki

3 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki

J. Zuber

2 Research Institute of Molecular Pathology, Vienna, Austria

V. Sexl

1 Dept. of Biomedical Sciences at the Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna